Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels

Fertility and Sterility

Volumn 93, Issue 4, 2010, Pages 1215-1219

  Manzanares, Maria A ^a   Gómez Palomares, Jose Lui ^a   Ricciarelli, Elisabetta ^a   Hernández, Eleuterio R ^a  

^a Grupo de Interés de Salud Embrionaria   (Spain)

Author keywords

GnRH agonist; OHSS; ovulation; PCO; pregnancy

Indexed keywords

CETRORELIX; DECAPEPTIL; ESTRADIOL; ESTRADIOL VALERATE; ETINILESTRADIOL/CIPROTERONA GINESERVICE; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; ORAL CONTRACEPTIVE AGENT; PROGEFFIK; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CRYOPRESERVATION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; OBSERVATIONAL STUDY; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE DRUG DOSE;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 77249138330     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.12.019     Document Type: Article

References (16)

1. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8 (2002) 559-577
2. Ovarian hyperstimulation syndrome. The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 86 (2006) S178-S183
3. ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-5
4. Itskovitz J., Boldes R., Levron J., Erlik Y., Kahana L., and Brandes J.M. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 56 (1991) 213-220
5. Itskovitz-Eldor J., Kol S., and Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report. Short communication. Hum Reprod 15 (2000) 1965-1968
6. Kol S.K. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 81 (2004) 1-5
7. Acevedo B., Gomez-Palomares J.L., Ricciarelli E., and Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril 86 (2006) 1682-1687
8. Hernández ER, Gomez JL, Ricciarelli E. No room for cancellation, coasting or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril. Published online 12 June 2008 [Epub ahead of print].
9. Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., and Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89 (2008) 84-1
10. Gómez-Palomares J.L., Acevedo-Martín B., Andrés L., Ricciarelli E., and Hernández E.R. LH improves early follicular recruitment in women over 38 years old. Reprod Biomed Online 11 (2005) 409-414
11. Palermo G.P., Joris H., Devroey P., and Van Steirteghem A.C. Pregnancy after intracytoplasmatic injection of a single spermatozoon into an oocyte. Lancet 340 (1992) 17-18
12. Veeck L.L. Atlas of Human Gametes and Conceptuses (1999), Parthenon Publishing Group, New York
13. Humaidan P., Ejdrup Bredkjaer H., Bungum L., Bungum M., Grondahl M.L., Westergaard L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20 (2005) 1213-1220
14. Kolibianakis E.M., Schultze-Mosgau A., Schroder A., van Steirteghem A., Devroey P., Diedrich K., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocytes maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005) 2887-2892
15. Griesinger G., Diedrich K., Devroey P., and Koliobinakis E.M. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 12 (2006) 159-168
16. Griesinger G., Koliobinakis E.M., Papanikolaou E.G., Diedrich K., Van Steirteghem A., Devroey P., et al. Triggering of final oocyte maturation with gonadotropins-releasing agonist or human chorionic gonadotropins. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 88 (2007) 616-621